GVAX vaccine using autologous: Began a Phase I trial

Patients will receive one of two doses, either 107 or 108 cells per vaccination, and will receive from one to four vaccinations based on disease progression and survival. Safety, immune response and levels of prostate-specific antigen will be monitored. ...